<DOC>
	<DOCNO>NCT00669721</DOCNO>
	<brief_summary>A randomise , prospective , cross study do determine whether anticoagulation therapy UFH LMWH use hemodialysis session modifies osteoprotegerin RANKL plasma level .</brief_summary>
	<brief_title>OPG RANKL Plasma Level After Administration Unfractionated Heparin ( UFH ) Low-Molecular-Weight Heparin ( LMWH ) Hemodialysis</brief_title>
	<detailed_description>It 's well know treatment heparin lead reduction bone density development osteoporosis [ 1 ] . Until , 's clear mechanism heparin produce side effect , several study animal [ 2,3 ] human [ 4 ] show LMWH may induce less osteoporosis UFH . Recently observe heparin interferes RANK/RANKL/POG system [ 5,6 ] . RANK , RANKL OPG member TNF alfa receptor superfamily . The pathway involve conjunction various cytokine calciotrophic hormone play pivotal role bone remodelling . In addiction experimental clinical study establish consistent relationship RANK/RANKL/OPG pathway skeletal lesion relate disorder mineral metabolism [ 7,8,9 ] vascular calcification [ 7,10 ] . OPG exist either active soluble form express osteoblast , stromal cardiovascular cell , act decoy receptor compete RANKL RANK . This interaction inhibit osteoclastic proliferation differentiation consequently prevent bone resorption . OPG also produce endothelial cell ( EC ) Vascular Smooth Muscle Cells ( VSMCs ) . EC-derived OPG seem act important autocrine / paracrine factor able protect arterial calcification block effect RANKL promote monocyte differentiation osteoclast -like cell osteogenic differentiation program VSMC . This process lead synthesis bone proteins matrix calcification within arterial vessel . OPG level increase age high ESRD patient [ 11,12 ] . Recently demonstrate culture murine bone marrow heparin inhibit osteoprotegerin activity bind OPG competitively way inhibit interaction OPG RANKL [ 5 ] . On side heparin seem cause mobilization OPG circulation . It report OPG co-localized vWF Weibel Palade body endothelial cell [ 13 ] bind Glucosaminoglycans ( GAGs ) cellular membrane highly basic heparin bind domain [ 14,15 ] . Heparin treatment cause immediate mobilization protein circulation displacement endothelial surface since high affinity heparins GAGs endothelial surface [ 16,17 ] . UFH cause pronounce vascular mobilization OPG LMWH , indicate UFH high affinity OPG LMWH [ 6 ] .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1. hemodialysis patient age &gt; 18 year regular bicarbonate hemodialysis hemodiafiltration treatment three time week ; 2. clinical stability least three month study start ; 1. active gastrointestinal bleeding ( one ore positive hemoccult test last 8 week , melena proctoraggia last 6 month ) 2. hemorrhagic stroke 3 . Myeloproliferative disorder 4 . Hereditary deficiency coagulation factor , LAC phenomenon antiphospholipid syndrome 5 . Malignant disease 6 . Patient submit antithrombotic prophylaxis LMWH 7 . Immunosuppressive therapy 8 . Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>osteoprotegerin</keyword>
	<keyword>RANKL</keyword>
	<keyword>heparin</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>vascular calcification</keyword>
</DOC>